Piper Sandler analyst Jason Bednar reiterated a Hold rating on Sonendo (SONX – Research Report) today and set a price target of $1.00. The company’s shares closed yesterday at $0.41.
Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Cooper Co, and DENTSPLY SIRONA. According to TipRanks, Bednar has an average return of -9.4% and a 34.36% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sonendo with a $1.38 average price target.
See today’s best-performing stocks on TipRanks >>
Based on Sonendo’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $11.04 million and a GAAP net loss of $17.69 million. In comparison, last year the company earned a revenue of $10.55 million and had a GAAP net loss of $15.14 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sonendo (SONX) Company Description:
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally.
Read More on SONX:
